---
figid: PMC11667780__cbm-21-1033-g002
figtitle: mTORis inhibit tumor metastasis to the lungs by suppressing EMT, tumor proliferation,
  and angiogenesis, whereas CNIs exert the opposite effect
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11667780
filename: cbm-21-1033-g002.jpg
figlink: /pmc/articles/PMC11667780/figure/F2/
number: F2
caption: mTORis inhibit tumor metastasis to the lungs by suppressing EMT, tumor proliferation,
  and angiogenesis, whereas CNIs exert the opposite effect. (1) mTORis first binds
  to FKBP12, forming an mTORi-FKBP12 complex, which then inhibits mTORC1 activity.
  This inhibition upregulates EpCAM expression and downregulates HIF1a and VEGF activity.
  (2) CNIs bind to FKBP12 to form a CNI-FKBP12 complex, which inhibits calcineurin
  activity. CNIs increase ROS levels, thereby activating the TGF-β/SMAD signaling
  pathway. Inhibition of calcineurin also activates the IFI27 and VEGFA pathways.
  (3) mTORi-induced upregulation of EpCAM suppresses EMT, while downregulation of
  HIF1α and VEGF inhibits angiogenesis and tumor proliferation. Conversely, the CNI-activated
  TGF-β/SMAD pathway promotes EMT and the IFI27 and VEGFA pathways enhance angiogenesis
  and tumor proliferation. FKBP12, FK506-binding protein 12; EpCAM, epithelial cell
  adhesion molecule; HIF1α, hypoxia-inducible factor 1-alpha; VEGF, vascular endothelial
  growth factor; ROS, reactive oxygen species; SMAD, Sma and Mad related protein;
  TGF-β, transforming growth factor beta; IFI27, interferon alpha-inducible protein
  27; VEGFA, vascular endothelial growth factor A
papertitle: 'Impact of immunosuppressants on tumor pulmonary metastasis: new insight
  into transplantation for hepatocellular carcinoma'
reftext: Jinyan Chen, et al. Cancer Biol Med. 2024 Nov 15;21(11).
year: '2024'
doi: 10.20892/j.issn.2095-3941.2024.0267
journal_title: Cancer Biology & Medicine
journal_nlm_ta: Cancer Biol Med
publisher_name: Chinese Anti-Cancer Association
keywords: Liver transplantation | hepatocellular carcinoma | lung immune microenvironment
  | lung metastasis | immunosuppressants
automl_pathway: 0.9497059
figid_alias: PMC11667780__F2
figtype: Figure
redirect_from: /figures/PMC11667780__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11667780__cbm-21-1033-g002.html
  '@type': Dataset
  description: mTORis inhibit tumor metastasis to the lungs by suppressing EMT, tumor
    proliferation, and angiogenesis, whereas CNIs exert the opposite effect. (1) mTORis
    first binds to FKBP12, forming an mTORi-FKBP12 complex, which then inhibits mTORC1
    activity. This inhibition upregulates EpCAM expression and downregulates HIF1a
    and VEGF activity. (2) CNIs bind to FKBP12 to form a CNI-FKBP12 complex, which
    inhibits calcineurin activity. CNIs increase ROS levels, thereby activating the
    TGF-β/SMAD signaling pathway. Inhibition of calcineurin also activates the IFI27
    and VEGFA pathways. (3) mTORi-induced upregulation of EpCAM suppresses EMT, while
    downregulation of HIF1α and VEGF inhibits angiogenesis and tumor proliferation.
    Conversely, the CNI-activated TGF-β/SMAD pathway promotes EMT and the IFI27 and
    VEGFA pathways enhance angiogenesis and tumor proliferation. FKBP12, FK506-binding
    protein 12; EpCAM, epithelial cell adhesion molecule; HIF1α, hypoxia-inducible
    factor 1-alpha; VEGF, vascular endothelial growth factor; ROS, reactive oxygen
    species; SMAD, Sma and Mad related protein; TGF-β, transforming growth factor
    beta; IFI27, interferon alpha-inducible protein 27; VEGFA, vascular endothelial
    growth factor A
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NT5C1A
  - FKBP1A
  - FKBP1AP1
  - FKBP1AP2
  - FKBP1AP3
  - FKBP1AP4
  - MTOR
  - RPTOR
  - MLST8
  - DEPTOR
  - AKT1S1
  - EPCAM
  - HIF1A
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - ITK
  - SLC22A3
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - mtor
  - mlst8
  - deptor
  - epcam
  - hif1ab
  - vegfaa
  - Raptor
  - cancer
  - Cancer
---
